Seasoned operator and investor focused on growth-stage technology and consumer sectors, with cross-functional experience in product strategy, corporate development and board governance. Nicole Reese brings strategic sourcing of growth capital, go-to-market scaling and M&A execution to portfolio companies, and is known for hands-on operational support to founders and CFOs. Frequently engages with VC and growth-equity firms to structure minority and control investments and drive commercial traction.
Seasoned operator and investor focused on growth-stage technology and consumer sectors, with cross-functional experience in product strategy, corporate development and board governance. Nicole Reese brings strategic sourcing of growth capital, go-to-market scaling and M&A execution to portfolio companies, and is known for hands-on operational support to founders and CFOs. Frequently engages with VC and growth-equity firms to structure minority and control investments and drive commercial traction.
Operates as a growth-stage investor prioritizing technology and consumer businesses with product-led expansion and repeatable go-to-market models. Prefers minority and structured control positions sized to catalyze scaling, using capital plus hands-on operational support in product strategy, commercial execution and M&A to accelerate value creation. Underwrites opportunities with emphasis on clear unit economics, scalable revenue channels and founder alignment, favors multi-year time horizons, active governance, and pragmatic risk mitigation via staged capital and performance-based milestones.
Operates as a growth-stage investor prioritizing technology and consumer businesses with product-led expansion and repeatable go-to-market models. Prefers minority and structured control positions sized to catalyze scaling, using capital plus hands-on operational support in product strategy, commercial execution and M&A to accelerate value creation. Underwrites opportunities with emphasis on clear unit economics, scalable revenue channels and founder alignment, favors multi-year time horizons, active governance, and pragmatic risk mitigation via staged capital and performance-based milestones.
| Trades 7756 | Longs Won 4584/7756 59% | Profit Factor 7.09 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $53,544.33 |
| Average Win $8,366.26 | Best Trade (Aug 14) $3.66M | Sharpe Ratio -11.04 |
| Average Loss -$1,705.2 | Worst Trade (Sep 01) -$275,282.65 | Z-Score 17.92 (100%) |
| Commissions $0 | Avg. Trade Length 10m 1w | Expectancy $4,247.3 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 100,000 | 90,000 | 80,000 | 70,000 | 60,000 | 50,000 | 40,000 | 30,000 | 20,000 | 10,000 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 45 | $6,045.25 | $6,349.95 | - | $304.7 | 5.04% | 0.0 |
AA Alcoa Corporation | 54 | $3,440.48 | $2,563.92 | - | -$876.56 | -25.48% | -0.44% |
AAL American Airlines Group Inc. | 1,256 | $14,718.99 | $20,410 | - | $5,691.01 | 38.66% | -1.99% |
AAOI Applied Optoelectronics, Inc. | 48 | $4,060 | $6,170.88 | - | $2,110.88 | 51.99% | 0.0 |
AAON Aaon Inc. | 36 | $4,225.4 | $3,353.4 | - | -$872 | -20.64% | 0.0 |
AAPL Apple Inc. | 9,661 | $2.45M | $3.02M | - | $567,117.59 | 23.14% | +0.453% |
AAT American Assets Trust, Inc. | 26 | $683 | $599.82 | - | -$83.18 | -12.18% | 0.0 |
AAXJ iShares MSCI All Country Asia ex Japan ETF | 6 | $433 | $664.32 | - | $231.32 | 53.42% | -2.647% |
ABBV AbbVie Inc. | 395 | $75,952.72 | $96,301 | - | $20,348.28 | 26.79% | -0.975% |
ABM ABM Industries Inc. | 524 | $23,182 | $25,466.4 | - | $2,284.4 | 9.85% | -0.674% |
ABNB Airbnb, Inc. | 4 | $477.85 | $609.96 | - | $132.11 | 27.65% | 0.0 |
ABT Abbott Laboratories | 527 | $58,360.66 | $55,577.42 | - | -$2,783.24 | -4.77% | -0.236% |
ABVX Abivax SA ADR | 432 | $49,791.49 | $56,160 | - | $6,368.51 | 12.79% | +3.677% |
ABX Abacus Global Management, Inc. | 66 | $494 | $696.96 | - | $202.96 | 41.09% | 0.0 |
ACAD Acadia Pharmaceuticals Inc. | 190 | $4,297.47 | $4,915.3 | - | $617.83 | 14.38% | -10.174% |
ACGL Arch Capital Group Ltd | 52 | $4,912.62 | $5,175.04 | - | $262.42 | 5.34% | +0.434% |
ACHC Acadia Healthcare Company, Inc. | 57 | $2,259.94 | $1,740.21 | - | -$519.73 | -23% | -5.304% |
ACI Albertsons Companies, Inc. | 2,243 | $44,496.97 | $26,579.55 | - | -$17,917.42 | -40.27% | 0.0 |
ACIW ACI Worldwide, Inc. | 25 | $1,297.84 | $1,382 | - | $84.16 | 6.48% | -4.343% |
ACLS Axcelis Technologies, Inc. | 46 | $5,919.76 | $6,031.52 | - | $111.76 | 1.89% | -4.061% |